News
- Author:
- Will Pass
Publish date: September 23, 2018
A combination of the mammalian target of rapamycin (mTOR) inhibitor everolimus and the BRAF inhibitor vemurafenib appears safe for patients with ad...
News
- Author:
- Will Pass
Publish date: September 22, 2018
Dr. Eve Espey says toxicity concerns must be addressed before a clinical roll out.
News
- Author:
- Will Pass
Publish date: September 21, 2018
Test results sorted patients into lower, intermediate, or higher risk for mortality.
News
- Author:
- Will Pass
Publish date: September 19, 2018
The guideline is comprehensive, consisting of both broad and specific descriptions of current ICU practices and associated evidence.
News
- Author:
- Will Pass
Publish date: September 18, 2018
Investigators planning phase 2 studies after phase 1b results demonstrated tolerability and efficacy with the combination of olaparib and trabected...
News
- Author:
- Will Pass
Publish date: September 17, 2018
The value proposition for the pricey CAR T-cell therapy depends on whether the real-world outcomes are as good as the ones seen in clinical trials....
News
- Author:
- Will Pass
Publish date: September 17, 2018
Use of serum biomarkers to distinguish IPF from other lung diseases wasn’t recommended.
News
- Author:
- Will Pass
Publish date: September 17, 2018
Stereotactic body radiation therapy (SBRT) is a safe and effective treatment option for patients with oligometastatic renal cell carci...
News
- Author:
- Will Pass
Publish date: September 16, 2018
Male gender and HLA-B27 positivity were found to be important predictors of a positive MRI.
News
- Author:
- Will Pass
Publish date: September 12, 2018
Inpatient costs also increased, but less dramatically.
News
- Author:
- Will Pass
Publish date: September 7, 2018
Checkpoint inhibitor therapy is effective for patients with HIV-associated Kaposi sarcoma (KS), a recent study has found.
Partia...
News
- Author:
- Will Pass
Publish date: September 5, 2018
Peroral endoscopic myotomy (POEM) is safe and effective for several nonachalasia esophageal motility...
News
- Author:
- Will Pass
Publish date: August 31, 2018
Nerve growth factor therapy in aging rats improves angiogenesis and speeds gastric ulcer healing, which suggests possible applications in human med...
News
- Author:
- Will Pass
Publish date: August 30, 2018
In the HAVEN 3 trial, patients with hemophilia A without inhibitors had a significant reduction in bleeding events and no thrombotic events.
News
- Author:
- Will Pass
Publish date: August 29, 2018
In patients with a high level of MET amplification, responses were more common, with almost half of the NSCLC patients responding.
